Pharma woes: Dinesh Thakur and Prashant Reddy on India’s regulatory shortcomings

The authors of The Truth Pill discuss India’s non-compliance with scientific methodology.

WrittenBy:NL Team
Date:
   
  • Share this article on whatsapp
subscription-appeal-image

Support Independent Media

The media must be free and fair, uninfluenced by corporate or state interests. That's why you, the public, need to pay to keep news free.

Contribute

In their 2022 book The Truth Pill, lawyer Prashant Reddy T and public health activist Dinesh S Thakur explored various aspects of modern pharmacology and pharmaceutical practices in India.

Now, in this conversation with Newslaundry’s Abhinandan Sekhri on February 9, they talked about the shortcomings of pharmaceutical regulations in India. Prashant quoted a former drug controller, who said, “If I had to apply American standards of quality to the Indian industry, I’ll have to shut down more than half the plants.”

This lack of regulatory accountability and non-compliance with scientific methodology can have serious consequences for consumers. Dinesh and Prashant explained other pressing concerns facing healthcare in India – rising drug failures, a surge in fixed-dose combinations, and the lack of regulatory structures for ayurvedic medicines.

Watch.

Venue partner: The Quorum, Gurgaon

Also see
article imageNL Interview: Katherine Eban on Big Pharma’s corrupt practices
article imageHafta 419: Big pharma in India, Parliament ruckus

You may also like